US Patent Issued to Vanda Pharmaceuticals on Sept. 9 for "Pharmaceutical combination comprising a selective S1P 1 receptor agonist" (Swiss Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,167, issued on Sept. 9, was assigned to Vanda Pharmaceuticals Inc. (Washington).

"Pharmaceutical combination comprising a selective S1P 1 receptor agonist" was invented by Martine Clozel (Allschwil, Switzerland) and Luca Piali (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical combination comprising a first active ingredient which is (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[Z]ylidene]-2-([Z]propylimino)-3-o-tolyl-thiazolidin-4-one or a pharmaceutically acceptable salt thereof and a second active ingredient which is selected from the group consisting of methyl fumarate, dimethyl...